Structured evidence table for Walnut Blood Pressure Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Walnut Blood Pressure Meta-Analysis | 1 2 3 2 4 5 6 7 8 Over the last three decades, a substantial body of evidence has been conducted regarding the management of hypertension (HTN) []. | 1 | Musazadeh Vali (2026) | Does Walnut Supplementation Have Favourable Effect Apolipoprotein A, B and Blood Pressure? A Systematic Review, Meta‐Analysis and Meta‐Evidence of Randomised Clinical Trials |
| Walnut Blood Pressure Meta-Analysis | Both the American Heart Association and the European Society of Hypertension recommend non‐pharmacological interventions such as reducing sodium intake, achieving weight loss and following a diet rich in fruits, vegetables and low‐fat dairy products, as outlined in the DASH (Dietary Approaches to Stop Hypertension) eating plan [,]. | 1 | Musazadeh Vali (2026) | Does Walnut Supplementation Have Favourable Effect Apolipoprotein A, B and Blood Pressure? A Systematic Review, Meta‐Analysis and Meta‐Evidence of Randomised Clinical Trials |
| Walnut Blood Pressure Meta-Analysis | The INTERHEART study demonstrated that the presence of just one risk factor can double or triple the overall risk of cardiovascular diseases. | 1 | Musazadeh Vali (2026) | Does Walnut Supplementation Have Favourable Effect Apolipoprotein A, B and Blood Pressure? A Systematic Review, Meta‐Analysis and Meta‐Evidence of Randomised Clinical Trials |
| Walnut Blood Pressure Meta-Analysis | HTN has a drastic correlation with age, and this correlation is more evident in Blacks than Whites []. | 1 | Musazadeh Vali (2026) | Does Walnut Supplementation Have Favourable Effect Apolipoprotein A, B and Blood Pressure? A Systematic Review, Meta‐Analysis and Meta‐Evidence of Randomised Clinical Trials |
| Walnut Blood Pressure Meta-Analysis | One of its principal risk factors is dyslipidemia, a metabolic disorder defined by elevated plasma levels of triglycerides (TG), total cholesterol (TC), low‐density lipoprotein cholesterol (LDL‐C), and apolipoprotein B (Apo‐B), alongside reduced concentrations of high‐density lipoprotein cholesterol (HDL‐C) and apolipoprotein A1 (Apo‐A1) (Arvanitis and Lowenstein ). | 1 | Mashayekhi Ghazal (2026) | Effects of Walnut Consumption on Blood Lipid Profile and Apolipoproteins in Adults: A GRADE ‐Assessed Systematic Review and Dose–Response Meta‐Analysis of 49 Randomized Controlled Trials |
| Walnut Blood Pressure Meta-Analysis | Likewise, Hwang et al. () found that 16 weeks of walnut supplementation increased HDL‐C levels but did not affect other lipid markers in individuals with metabolic syndrome. | 1 | Mashayekhi Ghazal (2026) | Effects of Walnut Consumption on Blood Lipid Profile and Apolipoproteins in Adults: A GRADE ‐Assessed Systematic Review and Dose–Response Meta‐Analysis of 49 Randomized Controlled Trials |
| Walnut Blood Pressure Meta-Analysis | demonstrated that three months of walnut consumption significantly reduced TC, LDL‐C, very low‐density lipoprotein cholesterol (VLDL‐C), and TG, while increasing HDL‐C in adults (Bashan and Bakman ). | 1 | Mashayekhi Ghazal (2026) | Effects of Walnut Consumption on Blood Lipid Profile and Apolipoproteins in Adults: A GRADE ‐Assessed Systematic Review and Dose–Response Meta‐Analysis of 49 Randomized Controlled Trials |
| Walnut Blood Pressure Meta-Analysis | Apo‐A1 Apo‐B HDL‐C LDL‐C RCT TC TG VLDL‐C 2025 2023 2015 2025 2006 Cardiovascular disease remains the foremost cause of morbidity and mortality worldwide (Chong et al. ). | 1 | Mashayekhi Ghazal (2026) | Effects of Walnut Consumption on Blood Lipid Profile and Apolipoproteins in Adults: A GRADE ‐Assessed Systematic Review and Dose–Response Meta‐Analysis of 49 Randomized Controlled Trials |
Source documents